Sonnet BioTherapeutics Holdings, Inc. (SONN)

Last Closing Price: 1.18 (2025-05-29)

Company Description

Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.02M
Net Income (Most Recent Fiscal Year) $-7.44M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 5.46
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -1312.60%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -777.92%
Return on Assets (Trailing 12 Months) -271.32%
Current Ratio (Most Recent Fiscal Quarter) 1.03
Quick Ratio (Most Recent Fiscal Quarter) 1.03
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $0.21
Earnings per Share (Most Recent Fiscal Quarter) $-0.89
Earnings per Share (Most Recent Fiscal Year) $-11.35
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 3.17M
Free Float 3.10M
Market Capitalization $3.74M
Average Volume (Last 20 Days) 0.03M
Beta (Past 60 Months) 0.95
Percentage Held By Insiders (Latest Annual Proxy Report) 2.00%
Percentage Held By Institutions (Latest 13F Reports) 9.45%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%